GENFIT
🏢 View company profile →66Patents
59Active
66Granted
54Portfolio score
Filing activity: Aug 22, 2001 → Nov 9, 2023 · 9 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8772342B2 | Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders | Human Necessities | 34 | Active |
| US7375135B2 | Fatty acid derivatives; preparation and uses thereof | Chemistry; Metallurgy | 32 | Expired |
| US8106097B2 | Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof | Chemistry; Metallurgy | 20 | Active |
| US7566737B2 | Combinations of substituted 1,3-diphenylprop-2-en-1-one derivatives with other therapeutically active ingredients | Chemistry; Metallurgy | 13 | Active |
| US8258182B2 | Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof | Chemistry; Metallurgy | 11 | Active |
| US11185519B2 | Methods of treatment of cholestatic diseases | Human Necessities | 10 | Active |
| US11331292B2 | Methods of treatment of cholestatic diseases | Human Necessities | 9 | Active |
| US7385082B2 | Preparation of 1,3-diphenylprop-2-en-1-one derivatives | Emerging Cross-Sectional Technologies | 7 | Expired |
| US11590108B2 | Pharmaceutical compositions for combination therapy | Human Necessities | 7 | Active |
| US11478440B2 | Combination of Elafibranor or derivatives thereof with an anti-NASH, anti-fibrotic or anti-cholestatic agent | Human Necessities | 7 | Active |
| US11484517B2 | Combination comprising a PPAR agonist such as elafibranor and an acetyl-CoA carboxylase (ACC) inhibitor | Human Necessities | 7 | Active |
| US8895619B2 | Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders | Human Necessities | 6 | Active |
| US7632870B2 | Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof | Chemistry; Metallurgy | 6 | Expired |
| US12053445B2 | Methods of treatment of cholestatic diseases | Human Necessities | 6 | Active |
| US11974997B2 | RORgamma modulators and uses thereof | Chemistry; Metallurgy | 6 | Active |
| US11857523B2 | Methods of treatment of cholestatic diseases | Human Necessities | 6 | Active |
| US11850223B2 | Methods of treatment of cholestatic diseases | Human Necessities | 6 | Active |
| US7547729B2 | 1,3-diphenylprop-2-en-1-one derivative compounds, preparation method thereof and uses of same | Chemistry; Metallurgy | 5 | Expired |
| US9221751B2 | Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders | Chemistry; Metallurgy | 5 | Active |
| US9585853B2 | Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders | Chemistry; Metallurgy | 3 | Active |
| US7943661B2 | Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US9902725B2 | Heterocyclic derivatives as RORgamma modulators | Chemistry; Metallurgy | 3 | Active |
| US8461183B2 | PPAR agonist compounds, preparation and uses | Chemistry; Metallurgy | 3 | Active |
| US9782373B2 | Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders | Chemistry; Metallurgy | 2 | Active |
| US8058308B2 | Substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.